Monika Rogozinska is a seasoned professional with extensive experience in the life sciences and biotech sectors. Currently serving as a Life Science Startup Advisor at Blackmon Technologies, Monika advises startups on strategy, development, and fundraising while judging ventures in prestigious competitions. Previous roles include Vice President of Pipeline & Program Management at DynamiCure Biotechnology, where Monika led R&D efforts, and Chief Development Officer at Adial Pharmaceuticals, focusing on asset development in the addiction space. Monika's career features leadership positions at Merck Group and Pfizer, managing global clinical development and substantial budgets. An alumnus of MIT Sloan School of Management with multiple executive certificates, Monika holds advanced degrees in Medical Laboratory Sciences and Business Administration, underscoring a strong educational foundation complemented by a passion for advancing health and innovation.